Skip to content

Managing acute diseases through polarity analysis

Polarity analysis in acute disease management: a repertorial approach using boenninghausens therapeutic pocket book - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2026/02/103684
Enrollment
45
Registered
2026-02-12
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: R688- Other general symptoms and signs

Interventions

Intervention1: Nil: Nil

Sponsors

Dr Vrushali Prashant Bansode
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1 ) Cases presenting with various and characteristic symptoms , modalities in all age group and both sexes will be included in my study. 2 ) Subject irrelated to age/gender were included in the study. 3) Patient presenting with acute conditions with clear onset and duration. 4) Cases with modality based symptom.

Exclusion criteria

Exclusion criteria: 1) Chronic Diseases. 2)Patient having advance and irreversible pathological conditions. 3)Patient who require emergency medical treatment. 4)Patient with unclear modalities

Design outcomes

Primary

MeasureTime frame
The study will assess clinical effectiveness by evaluating the rate of correct first-prescription remedy selection, based on symptom resolution. Remedy confirmation rate will be determined by follow-up symptoms and clinical response to the prescribed medicine.Timepoint: Outcome Assessment Will Be Done Only At Pre Study (Baseline) And Post Study At End Of 3 Months. Follow Up Visits Will Be Coducted evey 15 Days Durind This Period.

Secondary

MeasureTime frame
NILTimepoint: NIL

Countries

India

Contacts

Public ContactDr Vrushali Prashant Bansode

Sonajirao Kshirsagar Homoeopathic Medical College, Beed

dr.kailasgh78@gmail.com9822279818

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Mar 14, 2026